Institutional Career Development Core
Institutional Career Development Core
批准号:
10582666
负责人:
John R. Chan
金额:
$60.26万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-03-11 至 2025-02-28
关键词:
Applications GrantsArticulationClinicClinicalClinical ResearchClinical SciencesCommunitiesCompetenceDiseaseEducational CurriculumElementsEnvironmentEthicsFacultyFosteringFutureGoalsHealthHealth SciencesHumanIndividualInstitutionJournalsK-Series Research Career ProgramsKnowledgeManuscriptsMentorsMethodologyNew JerseyOutcomeProcessProductivityProgram DevelopmentPublic PolicyQualifyingRecording of previous eventsResearchResearch PersonnelResourcesSchoolsScienceScientific Advances and AccomplishmentsSocietiesStructureTeacher Professional DevelopmentTechnologyTrainingTranslatingTranslational ResearchUniversitiesWritingcareercareer developmentdidactic educationexperienceinnovationinterestknowledge basemeetingspersonalized approachpost-doctoral trainingprogramsrecruittooltranslational scientist
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The goal of the New Jersey Alliance for Clinical and Translational Science (NJ ACTS) Institutional Career
Development Award (KL2) is to expand the future pool of well-trained and productive investigators in the
biomedical sciences with a focus on clinical and translational research. Agnostic to terminal degree, the NJ ACTS
KL2 will provide a tailored approach for each Scholar that comprises intensive research experiences, a core
curriculum and elective courses, and extensive mentoring to develop a cadre of translational Scholars who
combine an understanding of the mechanistic approaches to study the disease and disease processes with the
tools and methodologies used in translating basic observations to the clinic and to public policy. NJ ACTS, an
Alliance of Rutgers University, Rutgers Biomedical and Health Sciences (which includes 8 health related schools),
Princeton University and the New Jersey Institute of Technology, constitute an environment rich with research
resources and experienced mentors, each with a history of post-doctoral training and faculty career development
and a commitment to fostering the career development of future clinical and translational researchers. Scholars,
who will be junior faculty, promoted from within NJ ACTS universities or recruited externally, will constitute a
Society of Scholars with other young faculty. Selection will be based not only on the individual's qualifications
and interests, but also on his/her potential and commitment to developing a career in the translational sciences.
In this revised application, the career development program consists of two years of individualized and intensive
research under the direction of the most qualified and productive mentors. Scholars will participate in an
innovative didactic curriculum consisting of research seminars, journal club, and formal courses. The mentoring
program is structured to provide the scholar with a strong, broad and fundamental knowledge base that is then
individually tailored for translational research. Scholars will be trained in the ethical conduct of research, will have
well defined milestones for accomplishing scientific goals, and will have regular meetings with Mentors, the
Executive Committee and leaders in the relevant academic community. The committed resources and programs
to enrich faculty development underscore the continued institutional commitment to translational research.
Anticipated outcomes include excellence in career development, and understanding and coherently articulating
science in the form of grant proposals, research that matters to human health, and competency in manuscript
writing. With these elements, we commit to nurturing a cadre of junior faculty that will discover and expand
scientific knowledge and become future leaders in the field of translational research.
期刊论文(4)
专著(0)
科研奖励(0)
会议论文
Use of a New Prevention Model in Acute Care Surgery: A Population Approach to Preventing Emergency Surgical Morbidity and Mortality.
在急症护理手术中使用新的预防模式:预防急诊手术发病率和死亡率的人群方法。
DOI:
10.1097/as9.0000000000000188
发表时间:
2022
期刊:
Annals of surgery open : perspectives of surgical history, education, and clinical approaches
影响因子:
--
作者:
[Peck,GregoryL, Hudson,ShawnaV, Roy,JasonA, Gracias,VicenteH, Strom,BrianL]
通讯作者:
Strom,BrianL
Perceived Benefits and Barriers of mHealth Mindfulness Use for Caregivers of Older Adults with Cognitive Impairment: A Qualitative Exploration.
认知障碍老年人护理人员使用移动健康正念的感知益处和障碍:定性探索。
DOI:
10.1080/07317115.2022.2154728
发表时间:
2024
期刊:
Clinical gerontologist
影响因子:
2.8
作者:
[Llaneza,DanielleH, Llaneza,AmandaJ, Kozlov,Elissa]
通讯作者:
Kozlov,Elissa
DOI:
10.1016/j.gastha.2023.03.023
发表时间:
2023
期刊:
Gastro hep advances
影响因子:
--
作者:
[Peck, Gregory L, Kuo, Yen-Hong, Nonnenmacher, Edward, Gracias, Vicente H, Hudson, Shawna V, Roy, Jason A, Strom, Brian L]
通讯作者:
Strom, Brian L
IgM in the regulation of TB immunity
-
批准号:10330559
-
项目类别:
-
资助金额:$74.74万
-
财政年份:2021
-
负责人:John R. Chan
-
依托单位:
IgM in the regulation of TB immunity
-
批准号:10531746
-
项目类别:
-
资助金额:$4.48万
-
财政年份:2021
-
负责人:John R. Chan
-
依托单位:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
-
批准号:9973940
-
项目类别:
-
资助金额:$92.6万
-
财政年份:2020
-
负责人:John R. Chan
-
依托单位:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
-
批准号:10685658
-
项目类别:
-
资助金额:$13.54万
-
财政年份:2020
-
负责人:John R. Chan
-
依托单位:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
-
批准号:10553212
-
项目类别:
-
资助金额:$85.65万
-
财政年份:2020
-
负责人:John R. Chan
-
依托单位:
The Rv2623-Rv1747 interaction: regulation of the in vivo fate of M. tuberculosis
-
批准号:10529446
-
项目类别:
-
资助金额:$88.5万
-
财政年份:2020
-
负责人:John R. Chan
-
依托单位:
IgM in the regulation of TB immunity
-
批准号:10551315
-
项目类别:
-
资助金额:$73.63万
-
财政年份:2019
-
负责人:John R. Chan
-
依托单位:
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
-
批准号:9921293
-
项目类别:
-
资助金额:$80.65万
-
财政年份:2018
-
负责人:John R. Chan
-
依托单位:
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
-
批准号:10395488
-
项目类别:
-
资助金额:$78.34万
-
财政年份:2018
-
负责人:John R. Chan
-
依托单位:
Humoral immunity against the M. tuberculosis kasB persistent mutant
-
批准号:9624948
-
项目类别:
-
资助金额:$8.94万
-
财政年份:2018
-
负责人:John R. Chan
-
依托单位:
Immunoregulation by indoleamine 2,3-dioxygenases in tuberculosis
-
批准号:10527562
-
项目类别:
-
资助金额:$29.99万
-
财政年份:2018
-
负责人:John R. Chan
-
依托单位:
"The Tuberculous Granuloma"
-
批准号:8871649
-
项目类别:
-
资助金额:$5.83万
-
财政年份:2015
-
负责人:John R. Chan
-
依托单位:
"The Tuberculous Granuloma"
-
批准号:8690741
-
项目类别:
-
资助金额:$34.97万
-
财政年份:2014
-
负责人:John R. Chan
-
依托单位:
"The Tuberculous Granuloma"
-
批准号:8049857
-
项目类别:
-
资助金额:$34.59万
-
财政年份:2011
-
负责人:John R. Chan
-
依托单位:
B cells and humoral immunity in tuberculosis
-
批准号:9132487
-
项目类别:
-
资助金额:$13.81万
-
财政年份:2011
-
负责人:John R. Chan
-
依托单位:
B cells and humoral immunity in tuberculosis
-
批准号:8584277
-
项目类别:
-
资助金额:$70.36万
-
财政年份:2011
-
负责人:John R. Chan
-
依托单位:
B cells and humoral immunity in tuberculosis
-
批准号:8396377
-
项目类别:
-
资助金额:$66.13万
-
财政年份:2011
-
负责人:John R. Chan
-
依托单位:
B cells and humoral immunity in tuberculosis
-
批准号:8223825
-
项目类别:
-
资助金额:$72.94万
-
财政年份:2011
-
负责人:John R. Chan
-
依托单位:
Animal Core
-
批准号:8049860
-
项目类别:
-
资助金额:$25.84万
-
财政年份:2011
-
负责人:John R. Chan
-
依托单位:
"The Tuberculous Granuloma"
-
批准号:8921330
-
项目类别:
-
资助金额:$12.91万
-
财政年份:2005
-
负责人:John R. Chan
-
依托单位:
海外基金